Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.

Autor: Fischer A; Institute of Human Genetics, Ulm University Medical Center, Ulm, Germany., Albert TK; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Moreno N; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Interlandi M; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.; Institute of Medical Informatics, University of Münster, 48149, Münster, Germany., Mormann J; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Glaser S; Institute of Human Genetics, Ulm University Medical Center, Ulm, Germany., Patil P; Institute of Human Genetics, Ulm University Medical Center, Ulm, Germany., de Faria FW; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Richter M; Institute for Experimental Pathology, Center for Molecular Biology of Inflammation, University of Münster, Münster, Germany., Verma A; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Balbach ST; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Wagener R; Institute of Human Genetics, Ulm University Medical Center, Ulm, Germany., Bens S; Institute of Human Genetics, Ulm University Medical Center, Ulm, Germany., Dahlum S; Institute of Human Genetics, Ulm University Medical Center, Ulm, Germany., Göbel C; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Eppendorf (UKE), 20251, Hamburg, Germany.; Research Institute Children's Cancer Center, 20251, Hamburg, Germany., Münter D; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Inserte C; Institute of Medical Informatics, University of Münster, 48149, Münster, Germany., Graf M; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Kremer E; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Melcher V; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Di Stefano G; Pathological Anatomy Section, Careggi University Hospital, Florence, Italy., Santi R; Pathological Anatomy Section, Careggi University Hospital, Florence, Italy., Chan A; Department of Pathology, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Dogan A; Department of Pathology, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Bush J; Division of Anatomical Pathology, British Columbia Children's Hospital and Women's Hospital and Health Center, Vancouver, BC, Canada., Hasselblatt M; Institute of Neuropathology, University Hospital Münster, 48149, Münster, Germany., Cheng S; Division of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, BC, Canada., Spetalen S; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Fosså A; Department of Oncology, Oslo University Hospital-Norwegian Radium Hospital, Oslo, Norway., Hartmann W; Division of Translational Pathology, Gerhard-Domagk-Institut für Pathologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude D17, 48149, Münster, Germany., Herbrüggen H; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Robert S; Department of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Münster, Münster, Germany., Oyen F; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Eppendorf (UKE), 20251, Hamburg, Germany., Dugas M; Institute of Medical Informatics, University of Münster, 48149, Münster, Germany.; Institute of Medical Informatics, Heidelberg University Hospital, Heidelberg, Germany., Walter C; Institute of Medical Informatics, University of Münster, 48149, Münster, Germany., Sandmann S; Institute of Medical Informatics, University of Münster, 48149, Münster, Germany., Varghese J; Institute of Medical Informatics, University of Münster, 48149, Münster, Germany., Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Schüller U; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Eppendorf (UKE), 20251, Hamburg, Germany.; Research Institute Children's Cancer Center, 20251, Hamburg, Germany.; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf (UKE), 20251, Hamburg, Germany., Tzankov A; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Pedersen MB; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., d'Amore FA; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Mellgren K; Department of Pediatric Oncology and Hematology, Sahlgrenska University Hospital, The Queen Silvia Children's Hospital, Gothenburg, Sweden., Kontny U; Section of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatric and Adolescent Medicine, RWTH Aachen University Hospital, Aachen, Germany., Kancherla V; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital, Lausanne, Switzerland., Veloza L; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital, Lausanne, Switzerland., Missiaglia E; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital, Lausanne, Switzerland., Fataccioli V; INSERM U955, Université Paris-Est, Créteil, France.; Département de Pathologie, Hôpitaux Universitaires Henri Mondor, AP-HP, INSERM U955, Université Paris Est Créteil, Créteil, France., Gaulard P; Département de Pathologie, Hôpitaux Universitaires Henri Mondor, AP-HP, INSERM U955, Université Paris Est Créteil, Créteil, France., Burkhardt B; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany., Soehnlein O; Institute for Experimental Pathology, Center for Molecular Biology of Inflammation, University of Münster, Münster, Germany., Klapper W; Department of Pathology, Haematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Kiel, Germany., de Leval L; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital, Lausanne, Switzerland., Siebert R; Institute of Human Genetics, Ulm University Medical Center, Ulm, Germany., Kerl K; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany. Kornelius.kerl@ukmuenster.de.

Publikováno v: Nature communications [Nat Commun] 2024 Oct 03; Vol. 15 (1), pp. 8571. Date of Electronic Publication: 2024 Oct 03.

Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas.

Autor: Erker C; Department of Pediatrics, Dalhousie University, Halifax, NS B3H 4R2, Canada.; Division of Pediatric Hematology-Oncology, IWK Health Centre, Halifax, NS B3K 6R8, Canada., Vanan MI; Pediatric Neuro-Oncology, Division of Pediatric Hematology-Oncology and BMT, Cancer Care Manitoba, 3a Department of Pediatrics and Child Health, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada., Larouche V; Department of Pediatric Hemato-Oncology, CHU de Québec-Université Laval, Quebec City, QC G1V 4G2, Canada., Nobre L; Department of Pediatrics, University of Alberta, Edmonton, AB T6G 2R3, Canada., Cacciotti C; Division of Hematology/Oncology, Department of Pediatrics, London Health Sciences Centre & Western University, London, ON N6A 5A5, Canada., Vairy S; Department of Pediatrics, Division of Pediatric Hematology, CHU Sherbrooke, QC J1H 5N4, Canada., Zelcer S; Division of Hematology/Oncology, Department of Pediatrics, London Health Sciences Centre & Western University, London, ON N6A 5A5, Canada., Fleming A; McMaster Children's Hospital, Hamilton, ON L8N 3Z5, Canada., Bouffet E; Department of Pediatrics, University of Toronto, Toronto, ON M5S 1A1, Canada.; Division of Hematology Oncology, The Hospital for Sick Children, Toronto, ON M5G 1E8, Canada., Jabado N; Montreal Children's Hospital, Montréal, QC H4A 3J1, Canada., Legault G; Montreal Children's Hospital, Montréal, QC H4A 3J1, Canada., Renzi S; Department of Pediatric Hemato-Oncology, CHU de Québec-Université Laval, Quebec City, QC G1V 4G2, Canada., McKeown T; Department of Pediatrics, University of Toronto, Toronto, ON M5S 1A1, Canada.; Division of Hematology Oncology, The Hospital for Sick Children, Toronto, ON M5G 1E8, Canada., Crooks B; Department of Pediatrics, Dalhousie University, Halifax, NS B3H 4R2, Canada.; Division of Pediatric Hematology-Oncology, IWK Health Centre, Halifax, NS B3K 6R8, Canada., Thacker N; Division of Hematology/Oncology, CHEO, Ottawa, ON K1H 8L1, Canada., Ramaswamy V; Department of Pediatrics, University of Toronto, Toronto, ON M5S 1A1, Canada.; Division of Hematology Oncology, The Hospital for Sick Children, Toronto, ON M5G 1E8, Canada., Coltin H; Division of Hematology Oncology, CHU Sainte-Justine, Montréal, QC H3T 1C5, Canada., Lafay-Cousin L; Alberta Children's Hospital, Calgary, AB T3B 6A8, Canada., Cheng S; B.C. Children's Hospital, Vancouver, BC V6H 3N1, Canada., Hukin J; B.C. Children's Hospital, Vancouver, BC V6H 3N1, Canada., Climans SA; Department of Oncology, Western University, London, ON N6A 3K7, Canada., Lim-Fat MJ; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M5S 1A1, Canada., McKillop S; Women and Children's Health Research Institute, University of Alberta, Edmonton, AB T6G 2R3, Canada., Lapointe S; Division of Neurology, Department of Neurosciences, Montreal, QC H3A 2B4, Canada.; Department of Neurosciences, University of Montreal, Montréal, QC H3T 1J4, Canada., Alves M; Department of Neurosciences, University of Montreal, Montréal, QC H3T 1J4, Canada., Bennett J; Department of Pediatrics, University of Toronto, Toronto, ON M5S 1A1, Canada., Tabori U; Department of Pediatrics, University of Toronto, Toronto, ON M5S 1A1, Canada.; Division of Hematology Oncology, The Hospital for Sick Children, Toronto, ON M5G 1E8, Canada., Perreault S; Department of Neurosciences, University of Montreal, Montréal, QC H3T 1J4, Canada.; Division of Child Neurology, CHU Sainte-Justine, Montréal, QC H3T 1C5, Canada.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jul 16; Vol. 31 (7), pp. 4022-4029. Date of Electronic Publication: 2024 Jul 16.

Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.

Autor: Peretz Soroka H; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Vora T; Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Noujaim J; Division of Medical Oncology, Hôpital Maisonneuve Rosemont, University of Montreal, Montreal, Quebec, Canada., Marcoux N; Division of Hematology-Oncology, Centre Hospitalier Universitaire de Québec, Quebec, Canada., Cohen-Gogo S; Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Alcindor T; Division of Medical Oncology, McGill University Health Centre, Montreal, Quebec, Canada., Holloway C; Division of Radiation Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Rodrigues C; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Karachiwala H; Division of Medical Oncology, Cross Cancer Institute, Alberta Health Services, Edmonton, Alberta, Canada., Alvi S; Division of Pediatric Hematology/Oncology, Jim Pattison Children's Hospital Saskatoon, Saskatoon, Saskatchewan, Canada., Lee U; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Cheng S; Division of Pediatric Hematology/Oncology/BMT, B.C. Children's Hospital, BC Cancer, Vancouver, British Columbia, Canada., Banerji S; Department of Pediatric Hematology-Oncology, CancerCare Manitoba Research Institute, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada., Oberoi S; Department of Pediatric Hematology-Oncology, CancerCare Manitoba Research Institute, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada., Feng X; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Smrke A; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Simmons C; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Razak AA; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.; Division of Medical Oncology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada., Gupta AA; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.; Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Publikováno v: Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (18), pp. 18872-18881. Date of Electronic Publication: 2023 Sep 19.

Whole genome transcriptome analysis in a case of a neonatal soft tissue sarcoma with YWHAE:NUTM2B fusion.

Autor: Locke A; School of Medicine, University of Galway, Galway, Ireland., Terry J; Division of Anatomy Pathology, Children's and Women's Health Centre of British Columbia, Vancouver, British Columbia, Canada., Shen Y; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Courtemanche D; Division of Plastic Surgery, University of British Columbia, Vancouver, British Columbia, Canada., Rosenbaum DG; Department of Radiology, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Rassekh SR; Division of Pediatric Hematology/Oncology/BMT, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Deyell RJ; Division of Pediatric Hematology/Oncology/BMT, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Cheng S; Division of Pediatric Hematology/Oncology/BMT, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Jul; Vol. 70 (7), pp. e30310. Date of Electronic Publication: 2023 Apr 05.

Neuroimaging to diagnose central nervous system tumours in children.

Autor: Cheng S, Goldman RD

Publikováno v: Canadian family physician Medecin de famille canadien [Can Fam Physician] 2023 Mar; Vol. 69 (3), pp. 165-167.